抗凝药物

  • 网络anticoagulants;anticoagulant drugs;NOAC;NOACs;IIa-C
抗凝药物抗凝药物
  1. 抗凝药物通过对凝血途径加以抑制而起效。

    Oral anticoagulants take effect by inhibiting the pathway of coagulation .

  2. 结论:肝硬化门脉高压症行脾切除,门脐静脉断流术的病人术后早期应用抗凝药物对预防门脉血栓的形成是必要的。

    Conclusion It is necessary to take the anticoagulants after the splenectomy due to the portal hypertension of hepatic cirrhosis .

  3. 降脂、抗凝药物预防激素所致股骨头骨细胞坏死、凋亡及对Bcl-2表达的影响

    Study on Antilipemic and Anticoagulant Preventing Necrosis and Apoptosis of Osteocytes in Steroid-induced Osteonecrosis of the Femoral Head

  4. 新型抗凝药物直接Xa因子抑制剂利伐沙班

    Novel anticoagulant , direct factor Xa inhibitor : Rivaroxaban

  5. 慢性口服抗凝药物对急性心肌梗死患者治疗和预后的影响:RICO调查资料

    Impact of chronic oral anticoagulation on management and outcomes of patients with acute myocardial infarction : Data from the RICO survey

  6. 我还想特别指出一些试验,这些试验观察了新型抗凝药物和抗血小板药物用于急性冠脉综合征或PCI。

    I would also like to highlight some other trials based on their use of new anti-coagulant and anti platelet agents either in the setting of acute coronary syndrome or PCI including the AVERROES Trial .

  7. 本研究旨在针对触发和非触发人群,当终止口服抗凝药物治疗后,探究如何识别VTE复发的最强预测因子。

    We aimed to identify the strongest predictors of VTE recurrence after discontinuation of oral anticoagulant therapy in a population of both provoked and unprovoked patients .

  8. 结论:不具有血栓栓塞高危因素的低危非瓣膜病AF患者,抗血小板药物阿司匹林与口服抗凝药物的疗效相似,但阿司匹林的剂量还需进一步研究。

    Conclusion : For low - risk patients dose - adjusted warfarin was no better than aspirin in the prevention of thromboembolism events and the combined events , but the optimal dose of aspirin needs further investigation .

  9. 结论大多数老年AF患者未使用抗凝药物,AF并发脑梗死的急性期处理尚不合理,亟需加强相关指南继续教育及建立中风单元,消除临床实际与指南的差距。

    Conclusion ( Most senior warfarin-eligible ) AF patients take no anticoagulation therapy and the acute treatment of stroke associated AF is suboptimal . The establishment of the stroke unit could improve the implementation of the guidelines and help to eliminate the gap between guidelines and clinical practice .

  10. 治疗组除行CSNB及手术当天停用抗血小板、抗凝药物外,其他药物处置与对照组相同。

    CSNB was administered to patients in treatment group , with the operation day the other treatment was the same as that in control group without anticoagulation drugs .

  11. 目的评估中国缺血性卒中(IS)或短暂性脑缺血发作(TIA)患者应用抗血栓药物(包括抗血小板药物和抗凝药物)的现况,并分析其影响因素。

    Objective To assess the current status of antithrombotic drug use ( including anticoagulant agents and antiplatelet drugs ) in patients with ischemic stroke ( IS ) or transient ischemic attack ( TIA ) in China and to analyze the possible factors that may affect the use of these drugs .

  12. 当万汶和佳乐施行AHHD使用剂量超过20ml/(kg.h)或病人近期应用抗凝药物,解热镇痛药物治疗或存在潜在出血性疾病时应慎重。

    When we perform AHHD by infusing more than 20 ml / ( kg · h ) solution ( voluven and gelofusine ), or the patient who has the treatment with anticoagulant , antipyretic analgesic recently or has potential hemorrhage disease , cautions should be taken .

  13. 一些病人测试的时候要停用阿司匹林和抗凝药物。

    Some patients were tested while discontinuing aspirin and anticoagulant therapies .

  14. 因此,凝血酶是研究抗凝药物的一个有效靶点。

    Thus , thrombin is the effective target for anticoagulant drugs .

  15. 抗血小板与抗凝药物在冠状动脉内支架植入术后的应用

    Antithrombotic Therapy with Antiplatelet and Anticoagulant Drugs after Intracoronary Stent Implantation

  16. 抗凝药物治疗对突发性聋疗效的影响

    The influence of anticoagulant therapy in the treatment of sudden deafness

  17. 术后长期口服抗凝药物是有效和安全的。

    Long-term anticoagulative therapy after the surgery is effective and safe .

  18. 常用抗血小板和抗凝药物在心脑血管疾病中的应用

    Application of Antiplatelet and Anticoagulation Drugs in Cardio-Cerebral Vascular Diseases

  19. 心脏瓣膜置换术后应用抗凝药物的护理干预和观察

    Nursing intervention and observation for patients applied anticoagulant after cardiac valve replacement

  20. 您认为抗凝药物的未来方向是什么?

    And what do you think about the future directions of anticoagulation drugs ?

  21. 抗凝药物与肺血栓栓塞症的临床应用评价

    Evaluation of Clinical Application of Anticoagulant Drugs in the Treatment of Pulmonary Thromboembolism

  22. 抗凝药物的临床应用及安全性评价

    Evaluation of Clinical Usage and Safety of Anticoagulant

  23. 心脏机械瓣膜置换后妊娠期抗凝药物的使用

    The follow up of pregnant women with anticoagulation therapy after mechanical heart valve replacement

  24. 结论低标准口服抗凝药物治疗对中国尤其是南方机械瓣置换术后患者具有可靠的临床可行性。

    Conclusion Lower standard oral anticoagulation therapy is feasible for the Southern Chinese people .

  25. 抗凝药物的相互作用与合理用药加强临床药学工作,促进儿科合理用药

    Supervise the clinical pharmaceutical care and improve the rational administration of drugs in pediatric clinic

  26. 使用抗血小板和抗凝药物是非常重要的,以尽量减少这些事件的发生。

    The use of these anti-platelet and anticoagulant drugs is quite important to minimize these events .

  27. 临床上常见的检查目的包括抗凝药物监测、出血倾向评估及常规术前凝血功能筛查。

    Their common uses include anticoagulation monitoring , bleeding tendency assessment and routine preoperative coagulation screening .

  28. 现在大部分医生都建议这种接受药物涂层支架植入的患者不定期的服用抗凝药物。

    Those who get drug-coated stents are now told by most doctors to take anti-clotting drugs indefinitely .

  29. 心脏瓣膜置换术后妇科再手术时抗凝药物的应用研究

    To study the application of anticoagulation therapy in department of gynecology and obstetrics operation after heart valve replacement

  30. 目的:观察危重型肾功能衰竭合并高危出血患者选择抗凝药物进行血液透析治疗的效果。

    Objective : To select optimal anticoagulant for patients with severe renal failure complicated with high risk bleeding .